Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Sattar N, Lee MMY, Kristensen SL, et al.
The Lancet Diabetes & Endocrinology. Pub online 20 August 2021
Leggi